The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 8 rounds in the feed, most often at Series D+ and in Biotech.
Investment firmbluepoolcapital.comRounds from 2017-09-18 to 2026-09-14
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Tabby The BNPL unicorn now expanding into consumer lending, SME finance and everyday money management | Series D+ Verified against 4 of 25 sources | $233M | 2026-09-14 | [ LEAD ] |
Tabby The BNPL unicorn now expanding into consumer lending, SME finance and everyday money management | Series E Verified against 2 of 3 sources |
| $160M |
| 2025-02-12 |
| [ LEAD ] |
GetYourGuide GetYourGuide sells tours and activities for travelers looking to explore various destinations and attractions around the world. | Series F Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $85M | 2023-06-01 | [ LEAD ] |
Premier Lacrosse League A men's professional lacrosse league in North America | Series D Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | n/a | 2022-07-21 | [ PART ] |
LifeMine LifeMine is a clinical-stage biopharmaceutical company that develops next-generation precision medicines through an innovative drug discovery approach focused on evolutionary insights from fungi, targeting patients in need of breakthrough therapies. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $175M | 2022-03-23 | [ PART ] |
Nex The company behind the popular family gaming console Nex Playground | Series B Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $25M | 2021-09-21 | [ LEAD ] |
LifeMine LifeMine is a clinical-stage biopharmaceutical company that develops next-generation precision medicines through an innovative drug discovery approach focused on evolutionary insights from fungi, targeting patients in need of breakthrough therapies. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $50M | 2021-01-07 | [ PART ] |
LifeMine LifeMine is a clinical-stage biopharmaceutical company that develops next-generation precision medicines through an innovative drug discovery approach focused on evolutionary insights from fungi, targeting patients in need of breakthrough therapies. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $55M | 2017-09-18 | [ PART ] |